Trending...
- The Social Capital Revolution Comes to Phoenix!
- Northeast Airlines aligns with European Investment Group
- Chicago: Mayor Brandon Johnson Announces City Has Made More Than $1 Billion in Supplemental Pension Payments Since 2023
CHICAGO, Jan. 11, 2022 /PRNewswire/ -- Today's draft decision by the Centers for Medicare & Medicaid Services (CMS) is shocking discrimination against everyone with Alzheimer's disease, especially those who are already disproportionately impacted by this fatal disease, including women, Blacks and Hispanics.
With this approach, access to treatment would now only be available to a privileged few, those with access to research institutions, exacerbating and creating further health inequities. In issuing its decision CMS has the audacity to cite the Alzheimer's Association 2021 Alzheimer's Disease Facts and Figures report on the challenges and barriers underrepresented communities have in participating in clinical trials, and then turn around and propose to impose those very barriers.
People living with Alzheimer's disease deserve the same access to therapies given to those living with other conditions like cancer, heart disease and HIV/AIDS. For those in the Administration to treat those with Alzheimer's disease differently than those with other diseases is simply unacceptable.
More on illi News
Critically, this draft decision is not about one treatment but about this class of potential future treatments targeting amyloid for the treatment of Alzheimer's disease. This draft decision appears focused on an individual treatment rather than a class, which is not what CMS set out to do.
CMS must change this draft decision. They must ensure equitable access for all who could benefit from FDA-approved treatments. The Alzheimer's Association calls on CMS to not only listen, but hear the needs of people living with dementia and their caregivers.
The above can be attributed to Harry Johns, Alzheimer's Association CEO.
Alzheimer's Association
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. For more information, visit www.alz.org or call the 24/7 Helpline at 800.272.3900.
SOURCE Alzheimer's Association
With this approach, access to treatment would now only be available to a privileged few, those with access to research institutions, exacerbating and creating further health inequities. In issuing its decision CMS has the audacity to cite the Alzheimer's Association 2021 Alzheimer's Disease Facts and Figures report on the challenges and barriers underrepresented communities have in participating in clinical trials, and then turn around and propose to impose those very barriers.
People living with Alzheimer's disease deserve the same access to therapies given to those living with other conditions like cancer, heart disease and HIV/AIDS. For those in the Administration to treat those with Alzheimer's disease differently than those with other diseases is simply unacceptable.
More on illi News
- Elie Tahari to Headline Chicago Fashion Summit and Receive Fashion Design Legacy Award
- Regional Magazines Shine at IRMA Awards
- Matt Zavala of Zavala Law, PC Selected to the 2027 Super Lawyers List
- Sawgrass Ford President Attributes Dealerships Success to Long-Term Employees
- Ragin' Cajun Announces New Cheeseburger Seasoning on National Cheeseburger Day
Critically, this draft decision is not about one treatment but about this class of potential future treatments targeting amyloid for the treatment of Alzheimer's disease. This draft decision appears focused on an individual treatment rather than a class, which is not what CMS set out to do.
CMS must change this draft decision. They must ensure equitable access for all who could benefit from FDA-approved treatments. The Alzheimer's Association calls on CMS to not only listen, but hear the needs of people living with dementia and their caregivers.
The above can be attributed to Harry Johns, Alzheimer's Association CEO.
Alzheimer's Association
The Alzheimer's Association leads the way to end Alzheimer's and all other dementia — by accelerating global research, driving risk reduction and early detection, and maximizing quality care and support. Our vision is a world without Alzheimer's and all other dementia®. For more information, visit www.alz.org or call the 24/7 Helpline at 800.272.3900.
SOURCE Alzheimer's Association
Filed Under: Business
0 Comments
Latest on illi News
- Gary Bernstein Expands Media Leadership Role With Senior Strategic Advisor Appointment To Blacksun Private Equity
- Litera Brings Foundation Firm AI Search into ChatGPT with Plugin
- Headline: House of Nova Paints Every Face in Gold at New York Fashion Week
- Can Government Operate Better Through Innovation?
- Michael H. Kaplan Advocates for Seriously Injured Colorado Workers Who Need In-Home Care
- Just Right Armrest Introduces an Adjustable Approach to Vehicle Arm Support
- Wig Floater Introduces a Convenient Magnetic Hanging Solution for Wig Storage
- Automated Mud Flap System Offers an Adjustable Approach to Heavy-Duty Vehicle Mud Flap Design
- Chicago: Mayor Brandon Johnson Announces City Has Made More Than $1 Billion in Supplemental Pension Payments Since 2023
- Chicago: Mayor Brandon Johnson, DPD Celebrate Completion of Winnslie Parkway Expansion in Ravenswood
- Chicago: Mayor Brandon Johnson Cuts Ribbon on Boulevard Apartments, Preserving 70 Affordable Homes Across Three Buildings
- Naperville: Structure Fire in the 30W000 Block of Argyll Lane
- Naperville's Annual Public Safety Open House Set for Sept. 26
- Infinity Infusion Solutions Named Finalist for D Magazine's D CEO 2026 Excellence in Healthcare Awards
- Canadian Tint Expo 2027: Why Every Window Tinter Should Compete in Niagara Falls on April 3rd & 4th
- The Drywall Helper Introduces a Versatile Approach to Measuring and Supporting Drywall
- InvisoScreen™ Introduces a New Approach to Window Screening
- Patented Smellavision Concept Aims to Add the Sense of Smell to Gaming and Entertainment
- Crib Notes Introduces an Interactive Approach to Early Alphabet Learning
- Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)